| # | Drug | Count |
|---|---|---|
| 0 | BASILIXIMAB | 2 |
| 1 | TACROLIMUS | 2 |
| 2 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 2 |
| 3 | TACROLIMUS OINTMENT 0.1% | 2 |
| 4 | VALGANCICLOVIR | 2 |
| 5 | VALGANCICLOVIR HYDROCHLORIDE | 2 |
| 6 | VALGANCICLOVIR HYDROCHLORIDE POWDER, | 2 |
| 7 | ACETAMINOPHEN | 1 |
| 8 | ACETAMINOPHEN 500MG | 1 |
| 9 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ANTIFUNGAL LIQUID SPRAY | 1 | 0.0053 |
| 1 | TOLNAFTATE 1% | 1 | 0.0034 |
| 2 | TOLNAFTATE | 1 | 0.0008 |
| 3 | BASILIXIMAB | 2 | 0.0002 |
| 4 | TERBINAFINE HYDROCHLORIDE TABLET | 1 | 0.0001 |
| 5 | TERBINAFINE HYDROCHLORIDE | 1 | 0.0001 |
| 6 | VALGANCICLOVIR | 2 | 0.0001 |
| 7 | FEBUXOSTAT TABLETS 40 MG | 1 | 0.0001 |
| 8 | PARICALCITOL | 1 | 0.0001 |
| 9 | FEBUXOSTAT | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vitamin D2 Analog [EPC] | 1 | 0.0001 |
| 1 | Allylamine Antifungal [EPC] | 1 | 0.0001 |
| 2 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 2 | 0.0001 |
| 3 | Vitamin D Analog [EPC] | 1 | 0.0001 |
| 4 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 1 | 0.0000 |
| 5 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Angiotensin Converting Enzyme Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Xanthine Oxidase Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Thiazide Diuretic [EPC] | 1 | 0.0000 |
| 9 | Opioid Agonist [EPC] | 1 | 0.0000 |